Grayzel David S. is a director of Surface Oncology, Inc.
Person profile
Roles
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aerovate Therapeutics, Inc.
11 Apr 24
4
Q32 Bio Inc.
27 Mar 24
3
Q32 Bio Inc.
27 Mar 24
4
Aerovate Therapeutics, Inc.
4 Jan 24
4
Surface Oncology, Inc.
8 Sep 23
4
Aerovate Therapeutics, Inc.
8 Jun 23
4
Aerovate Therapeutics, Inc.
5 Jan 23
4
Aerovate Therapeutics, Inc.
22 Jun 22
4
Surface Oncology, Inc.
10 Jun 22
4
Aerovate Therapeutics, Inc.
5 Jan 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
9 Apr 24 | AVTE Aerovate Therapeutics | Common Stock | Sell | Dispose S | Yes | No | 28.15 | 11,882 | 334.48 k | 14,502 |
25 Mar 24 | QTTB Q32 Bio | Stock Option Common Stock | Grant | Acquire A | No | No | 16.82 | 12,767 | 214.74 k | 12,767 |
2 Jan 24 | AVTE Aerovate Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 13.49 | 3,186 | 42.98 k | 3,186 |
8 Sep 23 | SURF Surface Oncology | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 2,945,453 | 0.00 | 0 |